1.Hepatitis C Virus Infection in Outpatient Clinic
Junichi TAZAWA ; Katsuhiro SANADA ; Yoshinori SAKAI ; Michio YAMANE ; Fumihiko KUSANO ; Kazuyoshi NAGAYAMA ; Hideomi FUJIWARA ; Susumu HIRANUMA
Journal of the Japanese Association of Rural Medicine 2004;53(2):110-117
The whole spectrum of patients infected with hepatitis C virus (HCV) who visited hospitals has not been fully clarified. It is also unknown whether such patients have visited the hospitals regularly thereafter for a long period. We studied 844 consecutive patients with liver diseases who visited our outpatient clinic located in the southern region of Ibaraki Prefecture. Five hundred eighty-three patients were HCV-infected. Among them, three patients were HBsAg-positive and another patient was IgM anti-HAV positive. Thus, 579 patients (68.6%) were considered to have HCV solely as a hepatotropic virus.Of these HCV patients, 60 were asymptomatic carriers and 15 others were unclassified because of the absence of either biopsy or imaging test records of the liver. As to the rest of the HCV patients, acute hepatitis was diagnosed in one patients, chronic hepatitis in 332 patients, cirrhosis in 130 patients and cancer of the liver in 41 patients.About half of the patients undergoing liver biopsy showed F1 in the degree of liver fibrosis. The rate of virological response to interferon mono-therapy in patients infected with genotype 2 was worse than the national average. The poor response was considered to be due to high viral load. It was suggested that the distribution of patients with each genotype was uneven in this region. After five years, the rate of patients still visiting our clinic were 68.1% for those with chronic hepatitis, and 50% for the healthy carriers. We deemed that it was important to clarify whether patients not visiting our clinic are followed up closely in other hospitals.
Hepatitis C virus
;
Liver
;
Clinic
;
Infection as complication of medical care
;
biopsy characteristics
2.Organ Correlation in IgG4-Related Diseases.
Satomi KOIZUMI ; Terumi KAMISAWA ; Sawako KURUMA ; Taku TABATA ; Kazuro CHIBA ; Susumu IWASAKI ; Go KUWATA ; Takashi FUJIWARA ; Junko FUJIWARA ; Takeo ARAKAWA ; Koichi KOIZUMI ; Kumiko MOMMA
Journal of Korean Medical Science 2015;30(6):743-748
IgG4-related disease (IgG4-RD) is a potentially multiorgan disorder. In this study, clinical and serological features from 132 IgG4-RD patients were compared about organ correlations. Underlying pathologies comprised autoimmune pancreatitis (AIP) in 85 cases, IgG4-related sclerosing cholangitis (IgG4-SC) in 12, IgG4-related sialadenitis (IgG4-SIA) in 56, IgG4-related dacryoadenitis (IgG4-DAC) in 38, IgG4-related lymphadenopathy (IgG4-LYM) in 20, IgG4-related retroperitoneal fibrosis (IgG4-RF) in 19, IgG4-related kidney disease (IgG4-KD) in 6, IgG4-related pseudotumor (IgG4-PT) in 3. Sixty-five patients (49%) had multiple IgG4-RD (two affected organs in 36 patients, three in 19, four in 8, five in 1, and six in 1). Serum IgG4 levels were significantly higher with multiple lesions than with a single lesion (P<0.001). The proportion of association with other IgG4-RD was 42% in AIP, the lowest of all IgG4-RDs. Serum IgG4 level was lower in AIP than in other IgG4-RDs. Frequently associated IgG4-RDs were SIA (25%) and DAC (12%) for AIP; AIP (75%) for IgG4-SC; DAC (57%), AIP (38%) and LYM (27%) for IgG4-SIA; AIP (26%) and LYM (26%) for IgG4-DAC; SIA (75%), DAC (50%) and AIP (45%) for IgG4-LYM; SIA (58%), AIP (42%) and LYM (32%) for IgG4-RF; AIP (100%) and SIA (67%) for IgG4-KID; and DAC (67%) and SIA (67%) for IgG4-PT. Most associated IgG4-RD lesions were diagnosed simultaneously, but IgG4-SIA and IgG4-DAC were sometimes identified before other lesions. About half of IgG4-RD patients had multiple IgG4-RD lesions, and some associations were seen between specific organs.
Adult
;
Aged
;
Autoimmune Diseases/*epidemiology/*immunology
;
Comorbidity
;
Female
;
Humans
;
Immunoglobulin G/*immunology
;
Japan/epidemiology
;
Male
;
Middle Aged
;
Multiple Organ Failure/*epidemiology/*immunology
;
Organ Specificity/immunology
;
Prevalence
;
Risk Factors
;
Statistics as Topic
3.Characteristic Findings of Endoscopic Retrograde Cholangiopancreatography in Autoimmune Pancreatitis.
Susumu IWASAKI ; Terumi KAMISAWA ; Satomi KOIZUMI ; Kazuro CHIBA ; Taku TABATA ; Sawako KURUMA ; Go KUWATA ; Takashi FUJIWARA ; Koichi KOIZUMI ; Takeo ARAKAWA ; Kumiko MOMMA ; Seiichi HARA ; Yoshinori IGARASHI
Gut and Liver 2015;9(1):113-117
BACKGROUND/AIMS: Diffuse or segmental irregular narrowing of the main pancreatic duct (MPD), as observed by endoscopic retrograde cholangiopancreatography (ERCP), is a characteristic feature of autoimmune pancreatitis (AIP). METHODS: ERCP findings were retrospectively examined in 40 patients with AIP in whom irregular narrowing of the MPD was detected near the orifice. The MPD opening sign was defined as the MPD within 1.5 cm from the orifice being maintained. The distal common bile duct (CBD) sign was defined as the distal CBD within 1.5 cm from the orifice being maintained. Endoscopic findings of a swollen major papilla and histological findings of specimens obtained from the major papilla were examined in 26 and 21 patients, respectively. RESULTS: The MPD opening sign was detected in 26 of the 40 patients (65%). The distal CBD sign was detected in 25 of the 32 patients (78%), which showed stenosis of the lower bile duct. The patients who showed the MPD opening sign frequently showed the distal CBD sign (p=0.018). Lymphoplasmacytic infiltration, but not dense fibrosis, was histologically detected in biopsy specimens obtained from the major papilla. CONCLUSIONS: On ERCP, the MPD and CBD adjacent to the major papilla are frequently maintained in patients with AIP involving the pancreatic head. These signs are useful for diagnosing AIP on ERCP.
Autoimmune Diseases/*diagnosis/pathology
;
*Cholangiopancreatography, Endoscopic Retrograde
;
Common Bile Duct/pathology
;
Female
;
Humans
;
Male
;
Middle Aged
;
Pancreas/pathology
;
Pancreatic Ducts/pathology
;
Pancreatitis/*diagnosis/pathology
;
Retrospective Studies
4.Chronic Kidney Disease As a Risk Factor of Stroke
Kenji KIKUCHI ; Kazuo SUZUKI ; Hisashi KOJIMA ; Katsuya FUTAWATARI ; Kenji MURAISHI ; Yoshitaka SUDA ; Junkoh SASAKI ; Susumu FUSHIMI ; Yasunari OTAWARA ; Toshirou OOTSUKA ; Hidehiko ENDO ; Makie TANAKA ; Naoko SUZUKI ; Kimiyo TAKAHASHI ; Yuko KIKUCHI ; Kozue IKEDA ; Mutsumi NITTA ; Mikiko FUJIWARA ; Miyuki NANBU ; Akiko TAKAHASHI ; Shousaku OGASAWARA
Journal of the Japanese Association of Rural Medicine 2014;63(4):596-605
Chronic kidney disease (CKD) has recently been reported to be an independent risk factor for stroke. However, a detailed analysis was yet to be conducted according to stroke subtype. We attempted to determine the risk factors for stroke using data from the “specific health checkup” for metabolic syndrome conducted by the 9 hospitals affiliated with the Akita Prefectural Federation of Agricultural Cooperatives, and evaluate and determine the risk factors for stroke. There were 401 patients who had undergone metabolic syndrome checkups from 2007 and 2010 and suffered from stroke afterwards within 3 years after the screening. The controls were all 69,407 subjects who were screened during the same period. The predictors examined were sex, age, blood pressure, BMI, cholesterol values (HDL・LDL), history of diabetes mellitus, presence of atrial fibrillation, CKD, and drinking and smoking habits. Analysis was conducted using logistic regression. The risk factors for stroke as a whole were male sex, age, blood pressure, diabetes, atrial fibrillation, CKD, and smoking history. For cerebral infarction, the risk factors were male sex, age, blood pressure, diabetes, atrial fibrillation, CKD, and smoking habit. The risk factors for cerebral hemorrhage were age, blood pressure, and CKD. For subarachnoid hemorrhage, the risk factors were female sex, age, blood pressure, low HDLemia, and CKD. In conclusion, CKD is an independent risk factor for the 3 subtypes of stroke, and in particular plays an important role as a higher risk factor for cerebral hemorrhage. Smoking cessation and controls of blood pressure, diabetes and atrial fibrillation are the important measures for stroke prevention. In addition, the further intervention should also be targeted to those with the result of CKD revealed by specific health checkups.
5.The Effectiveness of Byakkokaninjinto Added Gypsum Powder in 12 Patients with Atopic Dermatitis Refractory to Treatment Including Steroid Repellents
Atsushi YAMAMOTO ; Tomoe FUKUNAGA ; Atsushi NIIZAWA ; Nobukazu HORIE ; Saori YONETANI ; Michiko NAGAHAMA ; Susumu FUJIWARA ; Yozo YAMADA ; Atsushi FUKUNAGA ; Chikako NISHIGORI
Kampo Medicine 2018;69(2):133-139
We prospectively studied the effectiveness of byakkokaninjinto added gypsum powder for the treatment of atopic dermatitis (AD) by using the skin disease severity score, visual analogue scale (VAS) score for assessing itch severity, and Skindex-16 for assessing the quality of life (QOL) in 12 patients who were refractory to conventional treatments including steroid repellents. In addition, we retrospectively investigated for what types of “sho” (Kampo diagnosis) and eruptions this treatment was more effective. The results showed that the skin disease severity score and Skindex-16 significantly improved in 4 weeks. There was no significant improvement in eosinophil counts, IgE antibody levels, thymus and activation-regulated chemokine levels. Byakkokaninjinto added gypsum powder was found to be effective for the “sho” of “sensitive to heat” and “excessive sweating.” Thus, it can be one of the options in oral medicine for treating patients with intractable AD including steroid repellents because the rash improved in a short period of 4 weeks in our patients.